John T. Brandt

14.5k citations

110 papers · 11.1k indexed · 6 hit papers · h-index 47

Cardiology and Cardiovascular Medicine top 0.2%
Surgery top 0.5%
Hematology top 0.2%
Internal Medicine top 0.1%
Rheumatology top 0.2%

Co-authors: Douglas A. Triplett Barbara M. Alving I. Scharrer Kenneth J. Winters Christopher D. Payne Sandra Close Joseph A. Jakubowski Stephen D. Wiviott
Topics: Antiplatelet Therapy and Cardiovascular Diseases (30 papers)Venous Thromboembolism Diagnosis and Management (25 papers)Platelet Disorders and Treatments (19 papers)
Cited by: Internal Medicine Cardiology and Cardiovascular Medicine Hematology
Journals: New England Journal of Medicine Journal of Biological Chemistry Circulation
Partner nations: United States United Kingdom Japan

In The Last Decade

John T. Brandt

110 papers receiving 10.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

2008 1.7k citations Sandra Close, John T. Brandt et al. profile →
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

1995 965 citations John T. Brandt et al. PubMed profile →
Criteria for the Diagnosis of Lupus Anticoagulants: An Update

1995 808 citations John T. Brandt et al. profile →
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

2007 553 citations John T. Brandt, Sandra Close et al. Journal of Thrombosis and Haemostasis profile →
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel

2009 467 citations Sandra Close, John T. Brandt et al. profile →
Very high resolution canopy height maps from RGB imagery using self-supervised vision transformer and convolutional decoder trained on aerial lidar

2023 127 citations John T. Brandt et al. profile →

Peers

Countries citing papers authored by John T. Brandt

Since Specialization

Citations

This map shows the geographic impact of John T. Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Brandt more than expected).

Fields of papers citing papers by John T. Brandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Brandt. The network helps show where John T. Brandt may publish in the future.

Co-authorship network of co-authors of John T. Brandt

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Brandt. A scholar is included among the top collaborators of John T. Brandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Brandt. John T. Brandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantitative Measurement of Cell-Free Plasma DNA and Applications for Detecting Tumor Genetic Variation and Promoter Methylation in a Clinical Setting 2012 ·Journal of Molecular Diagnostics ·Sunil Kadam,Mark W. Farmen,John T. Brandt	21
2	Lamellar body counts on gastric aspirates for prediction of respiratory distress syndrome 2010 ·Acta Paediatrica ·Henrik Verder,Finn Ebbesen,John T. Brandt,(unknown),(unknown),(unknown),C Grytter,(unknown),Martin Nørgaard,J Reinholdt,(unknown)	19
3	Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease 2009 ·Journal of Clinical Pharmacy and Therapeutics ·D. S. Small,Rebecca E. Wrishko,C. Steven Ernest,Lan Ni,Kenneth J. Winters,Nazar Farid,(unknown),John T. Brandt,Daniel E. Salazar,(unknown),Keri A. Kles,Christopher D. Payne	61
4	Evaluation of anti‐activated protein C antibody development in patients with severe sepsis from four clinical studies with drotrecogin alfa (activated) 2009 ·Journal of Thrombosis and Haemostasis ·S. Betty Yan,John T. Brandt,(unknown),(unknown),James S. Bourdage	1
5	Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo 2008 ·Journal of the American College of Cardiology ·David Erlinge,Christoph Varenhorst,Oscar Ö. Braun,Stefan James,Kenneth J. Winters,Joseph A. Jakubowski,John T. Brandt,Atsuhiro Sugidachi,Agneta Siegbahn,Lars Wallentin	172
6	Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel 2008 ·The Journal of Clinical Pharmacology ·David S. Small,Nagy A. Farid,Christopher D. Payne,Govinda Weerakkody,Ying G. Li,John T. Brandt,Daniel E. Salazar,Kenneth J. Winters	245
7	Clopidogrel poor responders: An objective definition based on Bayesian classification 2007 ·Platelets ·Govinda J. Weerakkody,John T. Brandt,Christopher D. Payne,Joseph A. Jakubowski,Hideo Naganuma,Kenneth J. Winters	24
8	Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrelbreakdown → 2007 ·Journal of Thrombosis and Haemostasis ·John T. Brandt,Sandra Close,Stephen J. Iturria,Christopher D. Payne,Nazar Farid,C. Steven Ernest,D. Richard Lachno,Daniel E. Salazar,Kenneth J. Winters	553
9	Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel 2007 ·Journal of Cardiovascular Pharmacology ·Christopher D. Payne,(unknown),David S. Small,C. Steven Ernest,Nagy A. Farid,Joseph A. Jakubowski,John T. Brandt,Daniel E. Salazar,Kenneth J. Winters	135
10	A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement 2007 ·Journal of Thrombosis and Haemostasis ·Giancarlo Agnelli,Sylvia Haas,Jeffrey S. Ginsberg,K Krueger,Alex Dmitrienko,John T. Brandt	77
11	Quality Assurance in Hemostasis: The Perspective from the College of American Pathologists Proficiency Testing Program 2007 ·Seminars in Thrombosis and Hemostasis ·Mark T. Cunningham,John T. Brandt,Wayne L. Chandler,Charles Eby,Timothy E. Hayes,Jayashree Krishnan,Jerry B. Lefkowitz,John D. Olson,(unknown),Jun Teruya,Elizabeth Van Cott	26
12	External Peer Review Quality Assurance Testing in von Willebrand Disease: The Recent Experience of the United States College of American Pathologists Proficiency Testing Program 2006 ·Seminars in Thrombosis and Hemostasis ·Timothy E. Hayes,John T. Brandt,Wayne L. Chandler,Charles Eby,Kandice Kottke‐Marchant,Jayashree Krishnan,Jerry B. Lefkowitz,John D. Olson,(unknown),Elizabeth Van Cott,Mark T. Cunningham	33
13	Differential reactivity of anti-primate and anti-human secondary antibodies against human and monkey immunoglobulins: Implications for determining the sensitivity of immunogenicity assays 2005 ·Journal of Immunological Methods ·James S. Bourdage,John T. Brandt,Thomas N. Lee,Robert J. Konrad	1
14	Effect of double antigen bridging immunoassay format on antigen coating concentration dependence and implications for designing immunogenicity assays for monoclonal antibodies 2005 ·Journal of Pharmaceutical and Biomedical Analysis ·James S. Bourdage,Thomas N. Lee,(unknown),(unknown),John T. Brandt,Robert J. Konrad	18
15	Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum 2004 ·Journal of Pharmaceutical and Biomedical Analysis ·Chad Ray,Ronald R. Bowsher,Wendell C. Smith,Viswanath Devanarayan,(unknown),John T. Brandt,Robert A. Dean	110
16	College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy 1998 ·Archives of Pathology & Laboratory Medicine ·John D. Olson,Charles F. Arkin,John T. Brandt,Mark T. Cunningham,Alan R. Giles,John A. Koepke,David L. Witte	34
17	Phosphoinositide 3-Kinase and p72 Noncovalently Associate with the Low Affinity Fcγ Receptor on Human Platelets through an Immunoreceptor Tyrosine-based Activation Motif 1996 ·Journal of Biological Chemistry ·George Chacko,John T. Brandt,K. Mark Coggeshall,Clark L. Anderson	92
18	The Fc Receptor for Immunoglobulin G (FcγRII) on Human Platelets 1995 ·Seminars in Thrombosis and Hemostasis ·Clark L. Anderson,George Chacko,Jeanne M. Osborne,John T. Brandt	93
19	Identification of proteins in retinas and IPM from eyes with retinitis pigmentosa. 1988 ·PubMed ·Susan Y. Schmidt,(unknown),Ross B. Edwards,John T. Brandt,Alice J. Adler,Allen M. Spiegel,Hitoshi Shichi,Eliot L. Berson	13
20	Neutralization of thrombin by antithrombin III in the presence of cultured human fibroblasts 1988 ·Thrombosis Research ·John T. Brandt,Ralph E. Stephens,George H. Hinkle	2

About John T. Brandt

John T. Brandt is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 110 papers that have together received 11.1k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Venous Thromboembolism Diagnosis and Management (25 papers) and Platelet Disorders and Treatments (19 papers). The work is most often cited by research in Internal Medicine (2.4k citations), Cardiology and Cardiovascular Medicine (5.9k citations) and Hematology (2.8k citations). John T. Brandt has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Douglas A. Triplett, Barbara M. Alving, I. Scharrer, Kenneth J. Winters, Christopher D. Payne, Sandra Close, Joseph A. Jakubowski, Stephen D. Wiviott, Richard D. Hockett and Elliott M. Antman. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact